Are rabbit eyes and cell models suitable?
Assessment of safety and toxicity of genetic patches Inherited retinal diseases, such as Usher syndrome (deafblindness), are rare conditions that result in a gradual loss of vision. These diseases have […]
This author has not written his bio yet.
But we are proud to say that Ivonne Bressers contributed 471 entries already.
Assessment of safety and toxicity of genetic patches Inherited retinal diseases, such as Usher syndrome (deafblindness), are rare conditions that result in a gradual loss of vision. These diseases have […]
We invite international scientists to seize this unique opportunity and submit their most innovative research proposals. On October 8th, Stichting Ushersyndroom [Dutch Usher syndrome Foundation] officially opens its second international […]
On September 16, 2024, AAVantgarde Bio, a biotechnology company from Italy, announced that the first patient has been treated in a clinical study investigating the safety and efficacy of a […]
New insights from research Recent research by Mirthe Fehrmann and colleagues at Radboudumc has provided significant new insights into the long-term outcomes of cochlear implantation (CI) in people with Usher […]
Erwin van Wijk (Radboudumc) has recently received a substantial grant from the Foundation Fighting Blindness USA to create a large animal model in collaboration with the research groups of […]
On May 16th, it was Global Accessibility Awareness Day. Microsoft paid extensive attention to this by organizing an event at the Rijksmuseum in Amsterdam where they launched and explained their […]
NEW RESEARCH THANKS TO THE ‘USHER ACTIE RIJNSBURG’ FRIENDS GROUP Usher syndrome, characterized by sensorineural hearing loss and progressive Retinitis Pigmentosa (RP), presents a significant challenge for the medical community. […]
“The eye is such a beautiful and marvelously small organ, a highly specialized instrument with which we can perceive our environment in all its beauty and complexity.” Unfortunately, a lot […]
CLINICAL TRIAL BY AAVANTGARDE TO COMMENCE AAVantgarde, an international biotechnology company based in Italy and co-founded by Professor Alberto Auricchio, is dedicated to overcoming the limitations of adeno-associated virus (AAV) […]
UPDATE September 27, 2023 In mid-August, we reported that ProQR Therapeutics, which had previously been forced to halt its two promising clinical trials, had found a new partner in Laboratoires […]